How to Make It in the Urinary Tract: A Tutorial by

1. FoxmanB (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49: 53–70.

2. RonaldA (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 Suppl 1A: 14S–19S.

3. JohnsonJR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80–128.

4. BowerJM, EtoDS, MulveyMA (2005) Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6: 18–31.

5. SivickKE, MobleyHL (2010) Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78: 568–585.

6. LangermannS, MollbyR, BurleinJE, PalaszynskiSR, AugusteCG, et al. (2000) Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 181: 774–778.

7. ConnellI, AgaceW, KlemmP, SchembriM, MarildS, et al. (1996) Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93: 9827–9832.

8. BergstenG, WulltB, SchembriMA, LeijonhufvudI, SvanborgC (2007) Do type 1 fimbriae promote inflammation in the human urinary tract? Cell Microbiol 9: 1766–1781.

9. HunstadDA, JusticeSS (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64: 203–221.

10. ThomasWE, NilssonLM, ForeroM, SokurenkoEV, VogelV (2004) Shear-dependent ‘stick-and-roll’ adhesion of type 1 fimbriated Escherichia coli. Mol Microbiol 53: 1545–1557.

11. BishopBL, DuncanMJ, SongJ, LiG, ZaasD, et al. (2007) Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13: 625–630.

12. ApodacaG (2001) Stretch-regulated exocytosis of discoidal vesicles in urinary bladder epithelium. Urology 57: 103–104.

13. DhakalBK, MulveyMA (2009) Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. J Biol Chem 284: 446–454.

14. WrightKJ, SeedPC, HultgrenSJ (2007) Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 9: 2230–2241.

15. NicholsonTF, WattsKM, HunstadDA (2009) OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. Infect Immun 77: 5245–5251.

16. JusticeSS, LauerSR, HultgrenSJ, HunstadDA (2006) Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun 74: 4793–4800.

17. AndersonGG, GollerCC, JusticeS, HultgrenSJ, SeedPC (2010) Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun 78: 963–975.

18. LoughmanJA, HunstadDA (2012) Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis 205: 1830–1839.

19. DhakalBK, MulveyMA (2012) The UPEC pore-forming toxin alpha-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11: 58–69.

20. MulveyMA, SchillingJD, HultgrenSJ (2001) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69: 4572–4579.

21. HannanTJ, MysorekarIU, HungCS, Isaacson-SchmidML, HultgrenSJ (2010) Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 6: e1001042 doi:10.1371/journal.ppat.1001042.

22. CirlC, WieserA, YadavM, DuerrS, SchubertS, et al. (2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14: 399–406.

23. AshkarAA, MossmanKL, CoombesBK, GylesCL, MackenzieR (2008) FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 4: e1000233 doi:10.1371/journal.ppat.1000233.

24. RagnarsdottirB, SamuelssonM, GustafssonMC, LeijonhufvudI, KarpmanD, et al. (2007) Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 196: 475–484.

25. RagnarsdottirB, JonssonK, UrbanoA, Gronberg-HernandezJ, LutayN, et al. (2010) Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS ONE 5: e10734 doi:10.1371/journal.pone.0010734.

26. HopkinsWJ, ElkahwajiJ, KendziorskiC, MoserAR, BriggsPM, et al. (2009) Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice. J Infect Dis 199: 355–361.

27. SuhsKA, MarthalerBR, WelchRA, HopkinsWJ (2011) Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. MBio 2: e00094–00011.

28. DavisJM, CarvalhoHM, RasmussenSB, O'BrienAD (2006) Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun 74: 4401–4408.

29. ThumbikatP, BerryRE, SchaefferAJ, KlumppDJ (2009) Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect 11: 57–65.

30. KlumppDJ, WeiserAC, SenguptaS, ForrestalSG, BatlerRA, et al. (2001) Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect Immun 69: 6689–6695.

31. FloTH, SmithKD, SatoS, RodriguezDJ, HolmesMA, et al. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917–921.

32. FischbachMA, LinH, ZhouL, YuY, AbergelRJ, et al. (2006) The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A 103: 16502–16507.